Detailed answers about HASALIGIL & PARTNERS PHARMA CONSULTING LTD, including incorporation, status, business activity, and accounts information.
When was HASALIGIL & PARTNERS PHARMA CONSULTING LTD founded?
HASALIGIL & PARTNERS PHARMA CONSULTING LTD was officially incorporated on 14 April 2025 and is registered under company number 16386102. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is HASALIGIL & PARTNERS PHARMA CONSULTING LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of HASALIGIL & PARTNERS PHARMA CONSULTING LTD?
HASALIGIL & PARTNERS PHARMA CONSULTING LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does HASALIGIL & PARTNERS PHARMA CONSULTING LTD do?
HASALIGIL & PARTNERS PHARMA CONSULTING LTD operates in the following sector: 70229 - Management consultancy activities other than financial management. This provides insight into the company's primary business activity and industry focus.
What is HASALIGIL & PARTNERS PHARMA CONSULTING LTD's registered address?
The registered office address of HASALIGIL & PARTNERS PHARMA CONSULTING LTD is CHURCH COTTAGE CHURCH LANE, ARBORFIELD, READING, ENGLAND, RG2 9JA. This is the official address filed with Companies House for legal and statutory correspondence.
Is HASALIGIL & PARTNERS PHARMA CONSULTING LTD financially stable?
Financial accounts for HASALIGIL & PARTNERS PHARMA CONSULTING LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.